Author:
Grocholski Steven,Banerji Shantanu,Qing Gefei,Dawe David E.
Reference34 articles.
1. Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement: a retrospective analysis;Shaw;Lancet Oncol.,2011
2. First-line crizotinib versus chemotherapy in alk-positive lung cancer;Solomon;N. Engl. J. Med.,2014
3. Impact of the college of american pathologists, the international association for the study of lung cancer, and the association for molecular pathology clinical practice guidelines for EGFR and ALK testing in lung cancer In Canada;Ionescu;Curr. Oncol.,2013
4. ALK immunohistochemistry for ALK gene rearrangement screening in non-small cell lung cancer: a systematic review and meta-analysis;Pyo;Int. J. Biol. Mark.,2016
5. J. Le Quesne, M. Maurya, D. De Castro, S. Popat, A. Wotherspoon, A. Nicholson, A comparison of fish and immunohistochemistry in the detection of ALK rearrangement in lung adenocarcinoma, in: Proceedings of the 15th World Conference On Lung Cancer.1085, 2013.